<DOC>
	<DOCNO>NCT02096874</DOCNO>
	<brief_summary>Ultra-wide field fluorescein angiography detect response anti VGEF therapy Avastin retinal ischemia set diabetic macular edema .</brief_summary>
	<brief_title>Bevacizumab Peripheral Retinal Changes Wide Field Angiography Diabetic Macular Edema</brief_title>
	<detailed_description>The major cause vision loss diabetic retinopathy diabetic macular edema ( DME ) characterize thicken macula due abnormal leakage retinal vasculature . Ischaemic change microvascular pathology long hypothesize play role development DME . In diabetic retinopathy , ischaemia stimulates production vascular endothelial growth factor ( VEGF ) , lead breakdown blood-retinal barrier , may cause DME increase retinal vessel permeability . DME best evaluate optical coherence tomography ( OCT ) retinal ischemia determine Fluorescein angiography . With avaiability ultra wide field fluorescein angiography , investigator accurately measure degree ischemia peripheral retina . Thus , study provide u data degree retinal ischemia nonproliferative diabetic retinopathy ( NPDR ) proliferative diabetic retinopathy ( PDR ) case well measurable change occur retinal ischemia intra vitreal injection bevacizumab .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1 . Diabetic patient age &gt; 18year DME 2 . Scheduled Avastin therapy 3 . Adequate medium obtain OCT UWFA 1 . Macular pathology etiology 2 . Preexisting systemic disease cause retinal ischemia 3 . Previous laser antiVEGF treatment past 3 month 4 . Previous retina surgery past 2 month 5 . Allergy fluorescein dye 6 . Psychiatric disorder , Alzheimer disease Dementia disorder preclude followup continuation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Peripheral retinal ischemia</keyword>
	<keyword>ultra wide field fluorescein angiography</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>